Diuretic Effect of Aminophylline and Furosemide in Adult Patients Undergoing Cardiac Surgical Procedures
NCT07348510 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106
Last updated 2026-01-21
Summary
This work aims to investigate the diuretic effect of Aminophylline in comparison to Furosemide in adult patients undergoing cardiac surgical procedures.
Conditions
- Diuretic Effect
- Aminophylline
- Furosemide
- Cardiac Surgical Procedures
Interventions
- DRUG
-
Aminophylline
Patients will receive Aminophylline.
- DRUG
-
Furosemide
Patients will receive furosemide.
Sponsors & Collaborators
-
Cairo University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-01-17
- Primary Completion
- 2026-07-26
- Completion
- 2026-07-26
Countries
- Egypt
Study Locations
More Related Trials
-
Safety and Efficacy of Furosemide 40mg + Amiloride Hydrochloride 10mg to Reduct Edema
NCT01210365 ·Status: TERMINATED ·Phase: PHASE3
-
Inhaled Versus Intravenous Milrinone for Patients Undergoing Mitral Valve Replacement Surgery
NCT05838846 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Furosemide Treatment Before Blood Transfusion in Patients With Systolic Dysfunction
NCT01705470 ·Status: WITHDRAWN ·Phase: NA
-
Combination Oral Acetazolamide and Intravenous Furosemide on Acute Decompensated Heart Failure Outcomes
NCT06475105 ·Status: RECRUITING ·Phase: PHASE4
-
Short-term Efficacy of Furosemide, Isosorbide Dinitrate and Their Combination in ADHF
NCT02649998 ·Status: WITHDRAWN ·Phase: NA
-
Determining Optimal Dose and Duration of Diuretic Treatment in People With Acute Heart Failure (The DOSE-AHF Study)
NCT00577135 ·Status: COMPLETED ·Phase: PHASE3
-
Acute Effects of Furosemide on Hemodynamics and Pulmonary Congestion in Acute Decompensated Heart Failure.
NCT06024889 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Acetazolamide in Patients With Acute Heart Failure
NCT03720288 ·Status: UNKNOWN ·Phase: PHASE3
-
Cardioprotection on Chemotherapy-Induced Cardiotoxicity
NCT06853951 ·Status: RECRUITING ·Phase: PHASE3
-
Effects of Furosemide Plus Small HSS in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)
NCT04628325 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Metolazone and Intermittent Intravenous Furosemide Versus Continuous Infusion Furosemide in Acute Heart Failure
NCT00904488 ·Status: TERMINATED ·Phase: PHASE4
-
Sacubitril/Valsartan in Patients With Prosthetic Heart Valves With Heart Failure and Reduced Ejection Fraction
NCT07192341 ·Status: RECRUITING ·Phase: NA
-
Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure
NCT04384653 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Dapagliflozin on Cardiac Structure, Function and Secondary Mitral Regurgitation in Patients with Left Ventricle Dysfunction
NCT05849766 ·Status: COMPLETED ·Phase: PHASE3
-
Nitroglycerin vs. Furosemide Using Lung Ultrasound Pilot Trial
NCT03259165 ·Status: TERMINATED ·Phase: PHASE2
-
Torsemide Comparison With Furosemide for Management of Patients With Stable Heart Failure
NCT05093621 ·Status: COMPLETED ·Phase: PHASE3
-
Potential Drug Interactions With Bisoprolol in Egyptian Patients With ACS
NCT05536284 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome
NCT05536271 ·Status: COMPLETED ·Phase: PHASE2
-
Sacubitril-valsartan in Patients With Heart Failure.
NCT07341893 ·Status: COMPLETED ·Phase: NA
-
The Safety of Vardenafil in Patients Undergoing Cardiac Surgery
NCT01260285 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Furosemide Versus Vascular Filling in Patients With Acute Myocardial Infarction
NCT02905760 ·Status: UNKNOWN ·Phase: PHASE3
-
Dopamine in Acute Decompensated Heart Failure II
NCT01060293 ·Status: TERMINATED ·Phase: PHASE4
-
Pharmacokinetics and Pharmacodynamics of MTR105 in Hypotensive Cardiac Surgery Patients
NCT00482287 ·Status: WITHDRAWN ·Phase: PHASE2
-
Avoiding Treatment in the Hospital With Furoscix for the Management of Congestion in Heart Failure - A Pilot Study
NCT04593823 ·Status: COMPLETED ·Phase: PHASE2
-
Is Sacubitril-valsartan Superior to Dapagliflozin in Improving Myocardial Function Performance
NCT06090487 ·Status: COMPLETED ·Phase: NA